Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT00414869
Eligibility Criteria:
Inclusion Criteria:
* Male or non-pregnant female patients of at least 18 years old
* HVPG \> 12 mm Hg in fasting state on Day 1
* Free of any other condition (except liver failure) that may alter absorption, distribution, or elimination of drugs
Exclusion Criteria:
* Oesophageal bleeding in the previous 30 days
* Known intolerance to ursodeoxycholic acid or nitrates
* Liver cancer or liver metastasis from another cancer
* Portal hypertension secondary to venous thrombosis
* Presence of Transjugular Intrahepatic Portosystemic Shunt (TIPS)
* Severe liver failure (Child-Pugh C)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00414869
Study Brief:
Protocol Section:
NCT00414869